NCT Number: NCT00518414
The Evaluation of Cow Milk-Based Formulas
Infants will be fed infant formula and blood drawn to measure fatty acid levels in the blood.
Looking for future studies?
Notify MeKey information
Conditions
Age range
10 day–18 day
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Birmingham Pediatric Group, Birmingham, Alabama, United States
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy, term infant
- 10 to 18 days of age
Exclusion criteria
- Breast fed infants
- Infants with formula intolerance
Treatment and study plan
Milk-based infant formula with DHA and ARA
OtherMilk-based formula with DHA, ARA, prebiotics
OtherPrimary outcomes
-
Red Blood Cell (RBC) ARA and DHA
Time frame: 120 Days of age
Secondary outcomes
-
Phospholipid fatty acids, tolerance
Time frame: 120 Days of age
Sponsors and collaborators
Lead sponsor
Mead Johnson Nutrition
Industry
Registry information
Official study title
The Evaluation of Cow Milk-Based Formulas - Study A
Important dates
- Study start
- 2007
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Aug 20, 2007
- Registry last updated
- Sep 28, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Relationship Between Segmental Trunk Control and Gross Motor Performance in Low Birth Weight Born Infant
NCT04313478
Early Intervention, Low Birth Weight Infants
View Trial DetailsFollow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
NCT04389606
Healthy, Term Infants
Birmingham, Alabama, United States
View Trial DetailsThe Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease
NCT06092463
Atresia; Bowel, Congenital Abnormalities
Copenhagen, Denmark
View Trial Details